Scrip | What Does 2023 Hold for Biopharma?
Originally posted by Scrip on January 9, 2023.
Tony Crisman, Managing Director in Lincoln’s Healthcare Group, shares his predictions for biopharma mergers and acquisitions (M&A) trends in 2023.
Tony Crisman, Managing Director in Lincoln International’s Healthcare Group, reveals several anticipated 2023 biopharma mergers and acquisitions trends with Scrip.
- Sign up to receive Lincoln's perspectives
Meet Professionals with Complementary Expertise
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt
2022 Global Results
In 2022, Lincoln International continued to design and deliver meaningful solutions and outcomes for clients around the world. Our shared ambition for results achieved through collaboration, thoughtfulness and tailored approaches… Read More
Lincoln International Announces Managing Director Promotions 2022
Lincoln International, a global investment banking advisory firm, is pleased to announce the promotion of six Directors to Managing Director (MD), effective January 1, 2023. “Each of these individuals contributes… Read More
What’s Old is New Again: Value-Based Care Delivery in the Home
In 1930, physicians visiting patients in their residences represented 40 percent of all encounters. 20 years later this figure had fallen dramatically to just one visit in 10. By the… Read More
In Vivo Pharma Intelligence | The Growth Path for Drug Discovery Partners
Originally published by In Vivo Pharma Intelligence on November 15, 2022 James West, Director in Lincoln’s Healthcare Group, explains the key trends and mergers and acquisitions (M&A) dynamics in the… Read More
Lincoln International advised Accel-KKR on its sale of Cloud 9 Software to Planet DDS, a portfolio company of Aquiline Capital Partners and Level Equity
Lincoln International advised Reliable Medical, a portfolio company of Seven Hills Capital, on acquisition of Orbit Medical
Lincoln International advised H2 Equity Partners on agreement to sell Optegra to MidEuropa
Lincoln International advised Duomed a portfolio company of G Square has acquired the French and Belgian distribution activities of The Surgical Company
Lincoln International advised Odontolia, a portfolio company of DLF Venture, on raising growth capital from Siparex
Lincoln International advised PhyMed Healthcare Group has been sold in a series of transactions to strategic acquirers
Lincoln International advised MedTek on its sale to National Medical Billing Services, a portfolio company of Aquiline Capital Partners